Cody S. Harris

We represented Genentech as the victim of a massive trade secret theft by its former scientists and founders of JHL Biotech, which was developing biosimilar versions of Genentech’s cancer medicines. The Keker team reported the theft to the DOJ and FBI and cooperated with the government’s investigation, which led to the indictment, guilty pleas, and prison time for JHL’s founders and top executives. On the civil side, the team won a preliminary injunction forbidding JHL from commercializing its products. This broad injunction, which rested on a finding that Genentech had a likelihood of success on its trade secret misappropriation claims, led to a settlement with JHL, in which JHL agreed to abandon development of all four of its biosimilars of Genentech’s products, destroy all related cell lines, stipulate to a permanent injunction, fully cooperate with Genentech’s investigation, and reimburse Genentech for its legal fees.

We represent Qualcomm in a case brought by the FTC alleging that Qualcomm had failed to license its standard-essential patents at fair, reasonable and nondiscriminatory (FRAND) royalty rates and that Qualcomm had engaged in exclusionary conduct that increased its competitors’ costs and reduced their ability and incentive to innovate. Following a month-long bench trial, the district court issued an injunction that would have forced Qualcomm to license rival chip suppliers and renegotiate its existing licenses with cellphone makers. In August of 2020 the Ninth Circuit reversed the district court’s judgment and vacated the injunction.

We represent Qualcomm with respect to claims brought by a putative class of 250 million cellphone users alleging that Qualcomm inflated mobile device prices through its standard-essential patent licensing practices. We successfully overturned a nationwide class certification order before the Ninth Circuit and eliminated much of the case on a subsequent motion to dismiss.

Impax Laboratories, Inc. asked us to take over a false advertising case regarding the company's generic drug that had been litigated for two years. Within several months we took 20 depositions, secured five expert reports, and settled the case on very favorable terms for our client.

Hawaii's former governor and other shareholders claimed a start-up company had unfairly washed them out. They brought a breach of fiduciary duty lawsuit against numerous investment banks and institutional investors, including our client. We won dismissal of the case at the trial court, and settled the case on favorable terms.

We represented an investment fund executive charged with criminal tax fraud related to a tax-shelter transaction that the fund designed and implemented. We resolved the matter by negotiating a plea to reduced charges.

We advised Lucasfilm Ltd. in an investigation by the U.S. Department of Justice and then represented Lucasfilm in a series of antitrust class actions brought by former employees of Lucasfilm, Google, Apple and Pixar. Plaintiffs alleged unlawful agreements related to hiring and employee retention. Plaintiffs and Lucasfilm reached a preliminary settlement of plaintiffs’ claims in July 2013.

We defended Intuitive Surgical, Inc., a leading manufacturer of cutting-edge robotic surgery devices, from a securities class action. Plaintiffs alleged that Intuitive Surgical issued false and misleading statements regarding the company's financial results and prospects, when during the economic crisis of 2008, its financial results did not meet previously announced predictions. Plaintiffs’ lawyers filed a securities class action, which U.S. District Judge Lucy H. Koh dismissed with leave to amend. Then in a written opinion, Judge Koh agreed with each of our arguments, and dismissed the class action for the second time, this time with prejudice. Finally, the Ninth Circuit unanimously affirmed the dismissal in a 23-page published opinion.

We represented an audit firm in a purported class action brought by investors who blamed the auditors for failing to detect misconduct by investment firms. We prevailed in defeating class certification and the matter was resolved without any payment by our client.

We won summary judgment of non-infringement for Taiwan Semiconductor Manufacturing Company, Ltd. and its subsidiary TSMC, North America in a long-running patent lawsuit brought by North Carolina semiconductor company, Ziptronix, Inc. Ziptronix had asserted nine patents and more than 500 patent claims directed to TSMC’s manufacturing of semiconductors for use in backside-illumination image sensors used predominantly in smartphone cameras. On behalf of TSMC, we defeated Ziptronix’s claims by arguing that the territorial limits of U.S. patent law prohibited reaching TSMC’s business transactions and manufacturing operations in Taiwan.

To defend JM Eagle from a products liability, breach of implied warranty, and fraud action, we successfully drafted and argued a motion to dismiss. The motion was granted in its entirety, with the tort claims—which formed the backbone of the Complaint—all dismissed with prejudice.

Representing the County of Santa Clara, Keker, Van Nest & Peters won a nationwide injunction against President Donald J. Trump’s January 2017 executive order that attempted to defund state and local governments deemed to be “sanctuary jurisdictions.” KVP argued that the executive order violated the Constitution’s separation of powers, the Tenth Amendment, and the Fifth Amendment’s Due Process Clause. In granting the motion for a preliminary injunction, U.S. District Court Judge William H. Orrick determined that the County was likely to succeed on all four of its constitutional claims, and that the County is suffering immediate and irreparable harm.